Market Summary - March 25, 2026

Market Overview

On March 25, 2026, U.S. stock markets opened higher but experienced profit-taking as investors remained cautious amid ongoing geopolitical tensions, particularly regarding the situation in the Middle East. The Dow Jones Industrial Average rose by 363.66 points (0.79%) to 46,487, the S&P 500 increased by 50.59 points (0.77%) to 6,606, the Nasdaq gained 250.94 points (1.15%) to reach 22,012, and the Russell 2000 climbed 29.68 points (1.18%) to 2,535.

Geopolitical Context

U.S. stock futures surged overnight following reports that the U.S. had drafted a 15-point plan aimed at ending the ongoing conflict with Iran, which was communicated to Iran through Pakistan. This news initially led to a decline in Brent and WTI crude futures. However, Iran's Fars News Agency quickly refuted these claims, stating that they do not accept a ceasefire and deeming U.S. negotiations as "illogical." This back-and-forth has contributed to heightened market volatility, with the CBOE Volatility Index (VIX) remaining above 25.

Economic Data

Recent economic data showed that February import prices rose by 1.3% month-over-month, surpassing the consensus estimate of 0.5%. Non-petroleum import prices increased by 1.2%, while petroleum import prices rose by 2.5%. Export prices also saw a rise of 1.5%, indicating inflationary pressures in the economy.

Sector Performance

In terms of sector performance, small-cap stocks led the market, while defensive staples and real estate investment trusts (REITs) lagged. Technology, materials, and consumer discretionary sectors showed strength, particularly in semiconductors, which benefited from a surge in shares of ARM, Intel (INTC), and AMD due to positive news regarding AI chip developments.

Stock Movers

Gainers

• AIR: +9% after reporting better-than-expected Q3 results.
• ARM: +15% following projections of significant revenue from new AI data-center chips.
• BRZE: +20% after strong Q4 earnings results.
• CHWY: +14% despite missing revenue estimates, with improved gross margins.
• SRPT: +19% on positive results from experimental drug studies.

Losers

• AVXL: -27% after withdrawing its EU application for an Alzheimer’s drug.
• KBH: -4% due to a miss on earnings and revenue expectations.
• GNRC: -8% following a reorganization announcement.
• MAZE: -32% despite positive mid-stage study results for its experimental drug.
• SNDK: -8% amid weakness in memory stocks following Google's announcement of a new compression algorithm.

Conclusion

The market remains in a state of flux, heavily influenced by geopolitical developments and economic data. Investors are advised to stay vigilant as volatility persists, with daily headlines significantly impacting market movements.